Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Shemeica Binns"'
Publikováno v:
Case Reports in Anesthesiology, Vol 2018 (2018)
Chronic neuropathic pain and depression are often comorbid. Ketamine has been used to treat refractory pain. There is emerging evidence for use in depression. We present a case of a pediatric patient who was successfully treated with subanesthetic in
Externí odkaz:
https://doaj.org/article/833792387c704586928f1c104a7d5cf6
Autor:
Lois E. Shepherd, Judith-Anne W. Chapman, Paul E. Goss, Catherine A. Schnabel, Elizabeth Zarella, Lei Han, Tanja Badovinac-Crnjevic, Yi Zhang, Kathleen I. Pritchard, Michael Pollak, Mark G. Erlander, Dennis C. Sgroi, Shemeica Binns
Publikováno v:
Breast Cancer Research and Treatment. 157:101-108
Recent ASCO/CAP guidelines focus on decision making associated with the presence/absence of continuous breast biomarkers. Statistical standardization (SS) is demonstrated as a method to evaluate the effects of continuous RT-PCR biomarker expression l
Publikováno v:
Case Reports in Anesthesiology
Case Reports in Anesthesiology, Vol 2018 (2018)
Case Reports in Anesthesiology, Vol 2018 (2018)
Chronic neuropathic pain and depression are often comorbid. Ketamine has been used to treat refractory pain. There is emerging evidence for use in depression. We present a case of a pediatric patient who was successfully treated with subanesthetic in
Autor:
Hyman B. Muss, Paul E. Goss, Catherine A. Schnabel, Elizabeth Zarrella, Jackie Szymonifka, Dennis C. Sgroi, Yi Zhang, Erin Carney, Peggy L. Porter, Shemeica Binns, Dianne M. Finkelstein, Katherine I. Pritchard, David L. Rimm, James N. Ingle, Atul K. Bhan, Mark G. Erlander, Lois E. Shepherd, Dongsheng Tu, Lauren Steffel
Publikováno v:
JNCI Journal of the National Cancer Institute
Patients with hormone receptor–positive early breast cancer have a continuous yearly rate of recurrence extending out to 15 years after having received adjuvant endocrine therapy with tamoxifen for 5 years (1). More than half of the recurrences and
Autor:
Shemeica Binns, Elizabeth A. Richardson, Michael Pollak, L. Han, J-Aw Chapman, Mark G. Erlander, Lois E. Shepherd, Dennis C. Sgroi, Paul E. Goss, KI Pritchard, Catherine A. Schnabel, Yong Zhang
Publikováno v:
Cancer Research. 72:P1-07
Background: Poor inter-laboratory comparability of common clinically used breast cancer biomarkers led to a proposal of statistical standardization (SS) of laboratory results, similar to bone mineral density (BMD) z-scores. This analysis is the first
Autor:
Dipak Thakur, Elizabeth A. Richardson, Jonathan Bones, Shemeica Binns, Tomas Rejtar, Buffie Clodfelder-Miller, Dennis C. Sgroi, Sangwon Cha, Sonika Dahiya, Dongdong Wang, Barry L. Karger
Publikováno v:
Journal of Chromatography A. 1218:8168-8174
Precise proteomic profiling of limited levels of disease tissue represents an extremely challenging task. Here, we present an effective and reproducible microproteomic workflow for sample sizes of only 10,000 cells that integrates selective sample pr
Autor:
Kathleen I. Pritchard, Yi Zhang, Paul E. Goss, Lois E. Shepherd, Tanja Badovinac-Crnjevic, Mark G. Erlander, Catherine A. Schnabel, Lei Han, Judy-Anne W. Chapman, Michael Pollak, Dennis C. Sgroi, Elizabeth Zarella, Shemeica Binns
Publikováno v:
Breast Cancer Research : BCR
Background Biomarkers that can be used to accurately assess the residual risk of disease recurrence in women with hormone receptor–positive breast cancer are clinically valuable. We evaluated the prognostic value of the Breast Cancer Index (BCI), a
Autor:
Sgroi, Dennis, Judy-Anne Chapman, T. Badovinac-Crnjevic, Zarella, Elizabeth, Shemeica Binns, Zhang, Yi, Schnabel, Catherine, Erlander, Mark, Pritchard, Kathleen, Han, Lei, Shepherd, Lois, Goss, Paul, Pollak, Michael
RFS Kaplan-Meier plot of linear BCI for lymph nodeâ positive patients. (PDF 90 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::add3ffe8de703c6a7111e79be56e3656
Autor:
Sgroi, Dennis, Judy-Anne Chapman, T. Badovinac-Crnjevic, Zarella, Elizabeth, Shemeica Binns, Zhang, Yi, Schnabel, Catherine, Erlander, Mark, Pritchard, Kathleen, Han, Lei, Shepherd, Lois, Goss, Paul, Pollak, Michael
REMARK diagram for BCI investigations. (PDF 51 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bbfa6c85be0957bc32947a72a4be58a
Autor:
Judy-Anne W. Chapman, Lei Han, Lois Sheperd, Paul E. Goss, Elizabeth A. Richardson, Dennis C. Sgroi, Shemeica Binns, Cathy Schnabel, Kathy Pritchard, Yi Zhang, Mark G. Erlander, Michael Pollack
Publikováno v:
Cancer Research. 75:P6-01
Background: The continuous linear Breast Cancer Index (BCI) risk index combines the ratio of genes HOXB13 to IL17BR (H/I) and the molecular grade index (MGI) (Zhang et al, Clinical Cancer Research, 2013). The BCI signature was developed for node-nega